stockportfolio.pro
Stocks / BILL vs CLBT
BILL vs CLBT
BILL Holdings, Inc. and Cellebrite DI Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Technology.
| BILL Holdings, Inc. (BILL) | Cellebrite DI Ltd. (CLBT) | |
|---|---|---|
| Market cap | $3.2B | $3.2B |
| Revenue (latest FY) | $1.46B | $475.68M |
| Net income (latest FY) | $23.80M | $78.33M |
| Revenue growth (5y CAGR) | 56.1% | 20.7% |
| Net margin | 1.6% | 16.5% |
| Return on equity | 0.6% | 16.2% |
| P/E ratio | — | 45.5 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 1 | 2 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BILL — free Open CLBT — freeFrequently asked questions
Which is bigger, BILL or CLBT?
BILL Holdings, Inc. is larger by market capitalization — $3.2B versus $3.2B.
Which grows faster, BILL or CLBT?
Over the last five fiscal years, BILL Holdings, Inc. grew revenue faster — 56.1%/yr versus 20.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.